Advertisement
U.S. markets closed
Advertisement

China SXT Pharmaceuticals, Inc. (SXTC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.6100+0.4900 (+23.11%)
At close: 04:00PM EST
2.5200 -0.09 (-3.45%)
After hours: 07:58PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Performance Outlook
Previous Close2.1200
Open2.2300
Bid2.4600 x 900
Ask2.5400 x 1100
Day's Range2.0401 - 2.6400
52 Week Range1.6510 - 24.5000
Volume495,483
Avg. Volume177,828
Market Cap1.476M
Beta (5Y Monthly)0.81
PE Ratio (TTM)N/A
EPS (TTM)-22.2200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SXTC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • China SXT Pharmaceuticals, Inc.
    Analyst Report: Fastenal CompanyFastenal opened its first fastener store in 1967 in Winona, Minnesota. Since then, Fastenal has greatly expanded its footprint as well as its products and services. Today, Fastenal serves its 400,000 active customers through approximately 1,500 branches, over 1,600 on-site locations, and 14 distribution centers. Since 1993, the company has added other product categories, but fasteners remain its largest category at about 30%-35% of sales. Fastenal also offers customers supply-chain solutions, such as vending and vendor-managed inventory.
    Rating
    Fair Value
    Economic Moat
    10 months agoMorningstar
View more
  • GlobeNewswire

    China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule

    TAIZHOU, China, Oct. 26, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced that on October 19, 2023, NASDAQ notified us that it ha

  • GlobeNewswire

    China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split

    Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on October 5, 2023TAIZHOU, China, Oct. 04, 2023 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("T

  • Simply Wall St.

    China SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)

    China SXT Pharmaceuticals ( NASDAQ:SXTC ) Full Year 2023 Results Key Financial Results Net loss: US$5.93m (loss widened...